Banco Bilbao Vizcaya Argentaria, S.A. Biogen Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

$8.53 Billion
Q3 2024

A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 129,700 shares of BIIB stock, worth $19.5 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

129,700

Holding current value

$19.5 Million

% of portfolio

0.29%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $24.5 Million - $30.7 Million	129,700 New	129,700 $25.1 Million
Q2 2024 Aug 06, 2024	SELL	$190.52 - $236.72 $171,468 - $213,048	-900 Reduced 0.81%	110,008 $25.5 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $846,383 - $1.07 Million	-3,992 Reduced 3.47%	110,908 $23.9 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $7.47 Million - $8.99 Million	-33,541 Reduced 22.6%	114,900 $29.7 Million
Q3 2023 Nov 08, 2023	SELL	$253.3 - $285.89 $258,366 - $291,607	-1,020 Reduced 0.68%	148,441 $38.2 Million
Q2 2023 Aug 04, 2023	BUY	$275.25 - $318.06 $693,630 - $801,511	2,520 Added 1.71%	149,461 $42.6 Million
Q1 2023 May 09, 2023	BUY	$256.56 - $292.34 $2.03 Million - $2.31 Million	7,893 Added 5.68%	146,941 $40.9 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $5.74 Million - $6.97 Million	22,727 Added 19.54%	139,048 $38.5 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $3.65 Million - $5.03 Million	-18,734 Reduced 13.87%	116,321 $31.1 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $188,477 - $224,135	1,005 Added 0.75%	135,055 $27.6 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $2.58 Million - $3.25 Million	13,319 Added 11.03%	134,050 $28.6 Million
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $23.2 Million - $29.8 Million	103,510 Added 601.07%	120,731 $28.7 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $1.3 Million - $1.7 Million	4,610 Added 36.56%	17,221 $4.96 Million
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $79,772 - $127,730	308 Added 2.5%	12,611 $3.95 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $1.05 Million - $1.24 Million	-4,340 Reduced 26.08%	12,303 $3.34 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $400,224 - $602,437	1,694 Added 11.33%	16,643 $4.08 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $1.21 Million - $1.4 Million	-4,585 Reduced 23.47%	14,949 $4.24 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $3.27 Million - $4.33 Million	12,629 Added 182.9%	19,534 $5.23 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $2.16 Million - $2.74 Million	-8,022 Reduced 53.74%	6,905 $2.18 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $3.28 Million - $4.54 Million	14,927 New	14,927 $4.43 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.

Account

Banco Bilbao Vizcaya Argentaria, S.A. Biogen Inc. Transaction History